Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Soaring Growth Stock to Buy and Hold for 10 Years


Last year, shares of molecular diagnostics company Exact Sciences (NASDAQ: EXAS) dropped by about 40%. However, 2023 is proving to be very different, at least so far. Exact Sciences is up by 32% since the year started. There is no question that's an impressive performance, but it hardly constitutes a reason to invest.

Short-term gains are great, but can the company deliver market-beating returns over the long run? In my view, the answer is a resounding yes. Let's consider why it's worth buying shares of Exact Sciences today.

EXAS Chart

Continue reading


Source Fool.com

Like: 0
Share

Comments